Recombinant SARS-CoV-2 Spike antibody (RBD)
-
- Target See all SARS-CoV-2 Spike Antibodies
- SARS-CoV-2 Spike
- Antibody Type
- Recombinant Antibody
-
Binding Specificity
- RBD
-
Reactivity
- SARS Coronavirus-2 (SARS-CoV-2)
-
Host
-
Tobacco (Nicotiana benthamiana)
-
Clonality
- Monoclonal
-
Conjugate
- This SARS-CoV-2 Spike antibody is un-conjugated
-
Application
- ELISA, Western Blotting (WB)
- Purpose
- Human Anti-SARS-CoV-2 RBD (CR3022) Antibody
- Specificity
- CR3022 variable regions fused to human IgG1: Heavy chain CR3022 (GenBank: DQ168569.1) - Human Heavy chain IgG1 (UniProtKB/Swiss-Prot: P01857.1) Light chain CR3022 (GenBank: DQ168570.1) - Human kappa chain (UniProtKB/Swiss-Prot: P01834.2)
- Characteristics
- Monoclonal antibody to COVID-19 & SARS-CoV S glycoprotein. Recombinantly expressed in Nicotiana benthamiana plants.
- Purification
- This product was purified by Protein A affinity chromatography.
- Purity
- 90-95 %
- Immunogen
- SARS-CoV-2 RBD
- Clone
- CR3022
- Isotype
- IgG1
- Top Product
- Discover our top product SARS-CoV-2 Spike Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 2 mg/mL
- Buffer
- Phosphate Buffered saline (PBS) 0.1M pH 7.4. Preservative: none
- Preservative
- Without preservative
- Storage
- 4 °C,-20 °C
- Storage Comment
- Short term: 2 - 4°C. Long term: -20°C
-
- Target
- SARS-CoV-2 Spike
- Abstract
- SARS-CoV-2 Spike Products
- Synonyms
- E2 antibody, E2 glycoprotein precursor antibody, Surface Glycoprotein antibody, S antibody
-